| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | endopeptidase inhibitor activity | COL6A3 BIN1 COL28A1 OPRPN SERPINA11 C4A C4B SERPINA9 SERPINA5 | 1.59e-05 | 180 | 161 | 9 | GO:0004866 |
| GeneOntologyMolecularFunction | peptidase inhibitor activity | COL6A3 BIN1 COL28A1 OPRPN SERPINA11 C4A C4B SERPINA9 SERPINA5 | 2.15e-05 | 187 | 161 | 9 | GO:0030414 |
| GeneOntologyMolecularFunction | endopeptidase regulator activity | COL6A3 BIN1 COL28A1 OPRPN SERPINA11 C4A C4B SERPINA9 SERPINA5 | 3.79e-05 | 201 | 161 | 9 | GO:0061135 |
| GeneOntologyMolecularFunction | peptidase regulator activity | COL6A3 BIN1 COL28A1 OPRPN SERPINA11 C4A C4B SERPINA9 SERPINA5 | 2.46e-04 | 257 | 161 | 9 | GO:0061134 |
| GeneOntologyMolecularFunction | nuclear vitamin D receptor binding | 3.84e-04 | 18 | 161 | 3 | GO:0042809 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | CACNA1B ATP13A4 SLC5A10 TRPA1 SLC38A5 RYR2 CACNA2D4 SLC8B1 KCNH1 KCNN3 SLC4A5 SLC4A11 | 4.02e-04 | 465 | 161 | 12 | GO:0046873 |
| GeneOntologyMolecularFunction | phosphatidylethanolamine binding | 4.53e-04 | 19 | 161 | 3 | GO:0008429 | |
| GeneOntologyMolecularFunction | GABA receptor binding | 5.30e-04 | 20 | 161 | 3 | GO:0050811 | |
| GeneOntologyBiologicalProcess | metal ion transport | CACNA1B ATP13A4 BIN1 EPM2A SLC5A10 TRPA1 ANK3 SLC38A5 DYSF SLC22A17 RYR2 CBLIF CACNA2D4 SLC8B1 PPP3CA KCNH1 KCNN3 MLLT6 SLC4A5 NOS3 WNK4 WNK2 SLC4A11 | 3.63e-06 | 1000 | 162 | 23 | GO:0030001 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | CACNA1B ATP13A4 BIN1 EPM2A SLC5A10 TRPA1 ANK3 SLC38A5 DYSF SLC22A17 RYR2 CBLIF CACNA2D4 SLC8B1 PPP3CA KCNH1 KCNN3 MLLT6 SLC4A5 NOS3 WNK4 UNC80 WNK2 SLC4A11 | 1.25e-05 | 1157 | 162 | 24 | GO:0006812 |
| GeneOntologyBiologicalProcess | cellular response to nutrient levels | SREBF2 SRF GABARAP AMBRA1 MED1 WDR59 GABARAPL1 TNRC6A GABARAPL3 USF1 | 4.39e-05 | 262 | 162 | 10 | GO:0031669 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | CACNA1B ATP13A4 BIN1 SLC5A10 TRPA1 ANK3 SLC38A5 DYSF RYR2 CBLIF CACNA2D4 SLC8B1 PPP3CA KCNH1 KCNN3 SLC4A5 WNK4 UNC80 WNK2 SLC4A11 | 5.14e-05 | 942 | 162 | 20 | GO:0098655 |
| GeneOntologyBiologicalProcess | sodium ion transport | SLC5A10 ANK3 SLC38A5 SLC8B1 MLLT6 SLC4A5 NOS3 WNK4 WNK2 SLC4A11 | 6.58e-05 | 275 | 162 | 10 | GO:0006814 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | CACNA1B ATP13A4 BIN1 EPM2A SLC5A10 TRPA1 ANK3 SLC38A5 DYSF SLC22A17 RYR2 CBLIF CACNA2D4 SLC8B1 PPP3CA KCNH1 KCNN3 MLLT6 SLC26A11 SLC4A5 NOS3 WNK4 UNC80 WNK2 SLC4A11 | 7.11e-05 | 1374 | 162 | 25 | GO:0006811 |
| GeneOntologyBiologicalProcess | cellular response to nitrogen levels | 9.93e-05 | 12 | 162 | 3 | GO:0043562 | |
| GeneOntologyBiologicalProcess | cellular response to nitrogen starvation | 9.93e-05 | 12 | 162 | 3 | GO:0006995 | |
| GeneOntologyBiologicalProcess | positive regulation of miRNA transcription | 1.17e-04 | 61 | 162 | 5 | GO:1902895 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | CACNA1B ATP13A4 BIN1 SLC5A10 TRPA1 ANK3 SLC38A5 DYSF RYR2 CBLIF CACNA2D4 SLC8B1 PPP3CA KCNH1 KCNN3 SLC4A5 WNK4 WNK2 SLC4A11 | 1.18e-04 | 922 | 162 | 19 | GO:0098662 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | CACNA1B ATP13A4 BIN1 SLC5A10 TRPA1 ANK3 SLC38A5 DYSF RYR2 CBLIF CACNA2D4 SLC8B1 PPP3CA KCNH1 KCNN3 SLC26A11 SLC4A5 WNK4 WNK2 SLC4A11 | 1.46e-04 | 1017 | 162 | 20 | GO:0098660 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | CACNA1B ATP13A4 BIN1 SLC5A10 TRPA1 ANK3 SLC38A5 DYSF RYR2 CBLIF CACNA2D4 SLC8B1 PPP3CA KCNH1 KCNN3 SLC26A11 SLC4A5 WNK4 UNC80 WNK2 SLC4A11 | 1.79e-04 | 1115 | 162 | 21 | GO:0034220 |
| GeneOntologyBiologicalProcess | presynapse to nucleus signaling pathway | 1.83e-04 | 3 | 162 | 2 | GO:0099526 | |
| GeneOntologyBiologicalProcess | regulation of body fluid levels | CEACAM4 SRF MED1 TSPAN9 PPP3CA CELSR2 MLLT6 USF1 SLC4A5 NOS3 WNK4 IL6R | 2.01e-04 | 442 | 162 | 12 | GO:0050878 |
| GeneOntologyCellularComponent | dendrite | CACNA1B BIN1 EPM2A ANK3 PCLO INSR SREBF2 PUM2 GRM4 TENM2 PPP3CA GABARAPL1 KCNH1 C4A C4B BSN INPP5J EPHA3 | 1.13e-04 | 858 | 161 | 18 | GO:0030425 |
| GeneOntologyCellularComponent | sarcolemma | 1.15e-04 | 190 | 161 | 8 | GO:0042383 | |
| GeneOntologyCellularComponent | dendritic tree | CACNA1B BIN1 EPM2A ANK3 PCLO INSR SREBF2 PUM2 GRM4 TENM2 PPP3CA GABARAPL1 KCNH1 C4A C4B BSN INPP5J EPHA3 | 1.17e-04 | 860 | 161 | 18 | GO:0097447 |
| GeneOntologyCellularComponent | SREBP-SCAP-Insig complex | 1.76e-04 | 3 | 161 | 2 | GO:0032937 | |
| GeneOntologyCellularComponent | somatodendritic compartment | CACNA1B BIN1 EPM2A ANK3 PCLO INSR SREBF2 PUM2 APOB GRM4 TENM2 PPP3CA GABARAPL1 KCNH1 KCNN3 C4A C4B BSN IL6R INPP5J EPHA3 | 4.98e-04 | 1228 | 161 | 21 | GO:0036477 |
| GeneOntologyCellularComponent | axon | CACNA1B BIN1 TRPA1 ANK3 PCLO INSR SH2D3C GRM4 TENM2 TENM3 KCNH1 MYPN C4A C4B BSN UNC80 INPP5J | 5.30e-04 | 891 | 161 | 17 | GO:0030424 |
| Domain | Atg8 | 3.22e-05 | 8 | 158 | 3 | PF02991 | |
| Domain | Atg8-like | 3.22e-05 | 8 | 158 | 3 | IPR004241 | |
| Domain | Znf_piccolo | 7.11e-05 | 2 | 158 | 2 | IPR008899 | |
| Domain | zf-piccolo | 7.11e-05 | 2 | 158 | 2 | PF05715 | |
| Domain | Rhs_assc_core | 2.12e-04 | 3 | 158 | 2 | IPR022385 | |
| Domain | Serpin_fam | 3.22e-04 | 39 | 158 | 4 | IPR000215 | |
| Domain | Tox-GHH_dom | 4.22e-04 | 4 | 158 | 2 | IPR028916 | |
| Domain | PPR | 4.22e-04 | 4 | 158 | 2 | PF01535 | |
| Domain | Tox-GHH | 4.22e-04 | 4 | 158 | 2 | PF15636 | |
| Domain | Ten_N | 4.22e-04 | 4 | 158 | 2 | IPR009471 | |
| Domain | Ten_N | 4.22e-04 | 4 | 158 | 2 | PF06484 | |
| Domain | TENEURIN_N | 4.22e-04 | 4 | 158 | 2 | PS51361 | |
| Domain | Anaphylatoxin_comp_syst | 6.99e-04 | 5 | 158 | 2 | IPR018081 | |
| Domain | Anaphylatoxn_comp_syst_dom | 6.99e-04 | 5 | 158 | 2 | IPR001840 | |
| Domain | YD | 6.99e-04 | 5 | 158 | 2 | IPR006530 | |
| Domain | VWA | 7.33e-04 | 84 | 158 | 5 | SM00327 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | NCOA6 TOB2 SYNPO2 ANK3 POM121C USF3 EGR1 KLF5 SETBP1 MLLT6 BSN SAP130 WNK4 WNK2 ZMYM5 GAREM1 SON | 2.25e-11 | 430 | 162 | 17 | 35044719 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | CDC42BPG ANK3 UBE4B ERV3-1 SIPA1L3 INSR SREBF2 SRF ADGRG1 TSPAN9 SENP1 USF3 SLC8B1 LRFN2 PPP3CA GPR158 SETBP1 ELK3 ELK4 MBD5 SAP130 SLC4A5 TRAPPC9 GNL3 IL6R WNK2 | 6.50e-09 | 1489 | 162 | 26 | 28611215 |
| Pubmed | NCOA6 INSR SREBF2 GPAM APOB MED1 PPP3CA KLF5 INSIG2 USF1 NOS3 | 2.92e-08 | 250 | 162 | 11 | 18660489 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MON2 ZNF384 NCOA6 UBE4B SIPA1L3 AMBRA1 DYSF POM121C HDAC7 WDR59 CELSR1 SLC8B1 CELSR2 C19orf44 MLLT6 DTX2 MBD5 TRAPPC9 WNK2 GAREM1 | 2.44e-07 | 1105 | 162 | 20 | 35748872 |
| Pubmed | 3.95e-07 | 4 | 162 | 3 | 11414770 | ||
| Pubmed | SYNPO2 ANK3 SREBF2 NUP58 POM121C USF3 EGR1 FHOD1 TNRC6A C4A MBD5 WNK2 GAREM1 | 5.18e-07 | 486 | 162 | 13 | 20936779 | |
| Pubmed | MON2 TOB2 UBE4B PUM2 TENM2 RSBN1 LRFN2 TENM3 BAZ2A RABGAP1L ST18 SON | 5.21e-07 | 407 | 162 | 12 | 12693553 | |
| Pubmed | 9.85e-07 | 5 | 162 | 3 | 21393236 | ||
| Pubmed | Comparative analysis of the ternary complex factors Elk-1, SAP-1a and SAP-2 (ERP/NET). | 9.85e-07 | 5 | 162 | 3 | 7540136 | |
| Pubmed | 1.96e-06 | 6 | 162 | 3 | 18820683 | ||
| Pubmed | 3.42e-06 | 7 | 162 | 3 | 29233958 | ||
| Pubmed | Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome. | 3.42e-06 | 7 | 162 | 3 | 14660741 | |
| Pubmed | 3.42e-06 | 7 | 162 | 3 | 16651386 | ||
| Pubmed | COL27A1 SIPA1L3 GPAM POM121C WDR59 PARP4 USF3 DTX2 MBD5 TRAPPC9 UNC80 ADAMTSL2 | 3.80e-06 | 493 | 162 | 12 | 15368895 | |
| Pubmed | Genetic contributions of nonautoimmune SWR mice toward lupus nephritis. | 4.48e-06 | 24 | 162 | 4 | 11739537 | |
| Pubmed | Assessment of a polymorphism of SDK1 with hypertension in Japanese Individuals. | 4.90e-06 | 142 | 162 | 7 | 19851296 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | ZNF384 NCOA6 UBE4B GPATCH1 MED1 POM121C RSBN1 SENP1 BAZ2A SAP130 | 4.99e-06 | 341 | 162 | 10 | 32971831 |
| Pubmed | Association of genetic variants with hemorrhagic stroke in Japanese individuals. | 5.13e-06 | 143 | 162 | 7 | 20198315 | |
| Pubmed | 5.46e-06 | 8 | 162 | 3 | 28301559 | ||
| Pubmed | Potent and specific Atg8-targeting autophagy inhibitory peptides from giant ankyrins. | 8.16e-06 | 9 | 162 | 3 | 29867141 | |
| Pubmed | Mast cell protease 5 mediates ischemia-reperfusion injury of mouse skeletal muscle. | 8.16e-06 | 9 | 162 | 3 | 15905575 | |
| Pubmed | 1.16e-05 | 10 | 162 | 3 | 30429287 | ||
| Pubmed | 1.16e-05 | 10 | 162 | 3 | 30217973 | ||
| Pubmed | 2.12e-05 | 12 | 162 | 3 | 31801071 | ||
| Pubmed | Junctophilin-2 is necessary for T-tubule maturation during mouse heart development. | 2.12e-05 | 12 | 162 | 3 | 23715556 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 22737222 | ||
| Pubmed | Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection. | 2.16e-05 | 2 | 162 | 2 | 16565498 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 15998580 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 19062096 | ||
| Pubmed | Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice. | 2.16e-05 | 2 | 162 | 2 | 19933335 | |
| Pubmed | Bassoon and Piccolo maintain synapse integrity by regulating protein ubiquitination and degradation. | 2.16e-05 | 2 | 162 | 2 | 23403927 | |
| Pubmed | Structural basis for the C4d.1/C4d.2 serologic allotypes of murine complement component C4. | 2.16e-05 | 2 | 162 | 2 | 2459207 | |
| Pubmed | Antigen-induced B cell apoptosis is independent of complement C4. | 2.16e-05 | 2 | 162 | 2 | 17645767 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 12207352 | ||
| Pubmed | Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients. | 2.16e-05 | 2 | 162 | 2 | 27758680 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 22387014 | ||
| Pubmed | Role of Bassoon and Piccolo in Assembly and Molecular Organization of the Active Zone. | 2.16e-05 | 2 | 162 | 2 | 26793095 | |
| Pubmed | Complement C4 maintains peripheral B-cell tolerance in a myeloid cell dependent manner. | 2.16e-05 | 2 | 162 | 2 | 23749435 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 23918728 | ||
| Pubmed | Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein. | 2.16e-05 | 2 | 162 | 2 | 3037333 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 11726230 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 4216347 | ||
| Pubmed | Sequence determination of the thiolester site of the fourth component of human complement. | 2.16e-05 | 2 | 162 | 2 | 6950384 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 20332206 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 8660986 | ||
| Pubmed | Tissue-specific RNA processing for the complement C4 gene transcript in the H-2k mouse strain. | 2.16e-05 | 2 | 162 | 2 | 8428773 | |
| Pubmed | Alternative transcription initiation and splicing variants of the DHRS4 gene cluster. | 2.16e-05 | 2 | 162 | 2 | 18754758 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 24638111 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 17997710 | ||
| Pubmed | Transcriptional repression of C4 complement by hepatitis C virus proteins. | 2.16e-05 | 2 | 162 | 2 | 21345967 | |
| Pubmed | Active zone density is conserved during synaptic growth but impaired in aged mice. | 2.16e-05 | 2 | 162 | 2 | 21935939 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 2572548 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 2302180 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 23292348 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 22151770 | ||
| Pubmed | C4d-positive chronic rejection: a frequent entity with a poor outcome. | 2.16e-05 | 2 | 162 | 2 | 18091514 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 29080553 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 6589636 | ||
| Pubmed | C4 Deficiency is a predisposing factor for Streptococcus pneumoniae-induced autoantibody production. | 2.16e-05 | 2 | 162 | 2 | 25339671 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 17728371 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 30365040 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 6149580 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 6149581 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 12115608 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 3542363 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 2387317 | ||
| Pubmed | Serum response factor binding sites differ in three human cell types. | 2.16e-05 | 2 | 162 | 2 | 17200232 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 16908004 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 7365238 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 16455790 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 7391573 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 17971360 | ||
| Pubmed | Clinical features of patients with homozygous complement C4A or C4B deficiency. | 2.16e-05 | 2 | 162 | 2 | 29928053 | |
| Pubmed | Analysis of C4 and the C4 binding protein in the MRL/lpr mouse. | 2.16e-05 | 2 | 162 | 2 | 17971229 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 6881182 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 23544943 | ||
| Pubmed | Partial C4 deficiency in juvenile idiopathic arthritis patients. | 2.16e-05 | 2 | 162 | 2 | 17921792 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 21880985 | ||
| Pubmed | Amino acid sequence around the thiol and reactive acyl groups of human complement component C4. | 2.16e-05 | 2 | 162 | 2 | 6978711 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 35898513 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 28873507 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 276882 | ||
| Pubmed | Amino acid sequence of a polymorphic segment from fragment C4d of human complement component C4. | 2.16e-05 | 2 | 162 | 2 | 6832377 | |
| Pubmed | Hepatic insulin receptor deficiency impairs the SREBP-2 response to feeding and statins. | 2.16e-05 | 2 | 162 | 2 | 24516236 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 3794341 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 22785613 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 32691186 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 23335107 | ||
| Pubmed | Synaptic activity controls localization and function of CtBP1 via binding to Bassoon and Piccolo. | 2.16e-05 | 2 | 162 | 2 | 25652077 | |
| Pubmed | The androgen-dependent C4-Slp gene is driven by a constitutively competent promoter. | 2.16e-05 | 2 | 162 | 2 | 8390682 | |
| Pubmed | Structure and expression of murine fourth complement component (C4) and sex-limited protein (Slp). | 2.16e-05 | 2 | 162 | 2 | 3902619 | |
| Pubmed | Structural polymorphism of murine C4 and its linkage to H-2. | 2.16e-05 | 2 | 162 | 2 | 7373044 | |
| Pubmed | The chemical structure of the C4d fragment of the human complement component C4. | 2.16e-05 | 2 | 162 | 2 | 3696167 | |
| Pubmed | The B-box dominates SAP-1-SRF interactions in the structure of the ternary complex. | 2.16e-05 | 2 | 162 | 2 | 11406578 | |
| Pubmed | Restriction fragment length polymorphism of the murine C4 and Slp genes: two C4 groups. | 2.16e-05 | 2 | 162 | 2 | 1357031 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 15473316 | ||
| Pubmed | Structural comparison of human C4A3 and C4B1 after proteolytic activation by C1s. | 2.16e-05 | 2 | 162 | 2 | 16098595 | |
| Pubmed | Increased frequency of C4B*Q0 alleles in patients with Henoch-Schönlein purpura. | 2.16e-05 | 2 | 162 | 2 | 15787745 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 20858904 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 30026462 | ||
| GeneFamily | Adhesion G protein-coupled receptors, subfamily C|CELSR cadherins | 1.18e-04 | 3 | 114 | 2 | 913 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily C|CELSR cadherins | 1.18e-04 | 3 | 114 | 2 | 1189 | |
| GeneFamily | CD molecules|Mucins | 2.99e-04 | 21 | 114 | 3 | 648 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 1.38e-03 | 9 | 114 | 2 | 1234 | |
| GeneFamily | Serpin peptidase inhibitors | 1.62e-03 | 37 | 114 | 3 | 739 | |
| GeneFamily | Zinc fingers CXXC-type|Methyl-CpG binding domain containing | 2.09e-03 | 11 | 114 | 2 | 1025 | |
| GeneFamily | Collagens | 3.04e-03 | 46 | 114 | 3 | 490 | |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 3.92e-03 | 15 | 114 | 2 | 26 | |
| ToppCell | Adult-Epithelial-club_cell|Adult / Lineage, Cell type, age group and donor | 3.24e-08 | 190 | 161 | 9 | 756bff697d30aec56c0ebfca94295f084a15bf37 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 3.39e-08 | 191 | 161 | 9 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | facs-Aorta-Heart-3m-Endothelial|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-08 | 195 | 161 | 9 | 8493f2f60fc356af28b9c0e287d4cd8c8899c081 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.06e-08 | 195 | 161 | 9 | e7230a849ea31e6eef9bc6f5468938499450582d | |
| ToppCell | facs-Aorta-Heart-3m-Endothelial-aortic_endothelial_cell|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-08 | 195 | 161 | 9 | 5e5ca7bd94c9e924ed76f7ccac199be745d4c4eb | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | MON2 ANK3 SIPA1L3 AMBRA1 INO80D RABGAP1L TNRC6A MBD5 TRAPPC9 | 4.83e-08 | 199 | 161 | 9 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.04e-08 | 200 | 161 | 9 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.04e-08 | 200 | 161 | 9 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | Control-Epithelial_alveolar-Mes-Like|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.22e-07 | 116 | 161 | 7 | df7609503782d8d7e4f31ed2a626916e5474d5bc | |
| ToppCell | droplet-Trachea-nan-3m-Endothelial|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.70e-07 | 184 | 161 | 8 | fa5c3020e75fdde1363393dea97ebd99f1eae9ff | |
| ToppCell | droplet-Trachea-3m-Endothelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.70e-07 | 184 | 161 | 8 | ad520ab6bb776b5303df505b7e1afb22484f18a7 | |
| ToppCell | droplet-Trachea-nan-3m-Endothelial-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.70e-07 | 184 | 161 | 8 | 1d63cb75a89c5f3f3b9ebf7fce8cb0fd4a92b645 | |
| ToppCell | droplet-Trachea-nan-3m-Endothelial-endothelial_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.70e-07 | 184 | 161 | 8 | 76caad53d55fff5acca27bf190a6de7b27437d9f | |
| ToppCell | droplet-Trachea-3m-Endothelial-endothelial_cell_of_trachea|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.70e-07 | 184 | 161 | 8 | 1fc1f0a3b4dbb085ebcc3960f67be24a108fe5b9 | |
| ToppCell | droplet-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.70e-07 | 184 | 161 | 8 | 2467207aaea307873ab286f89cfc7668a227a694 | |
| ToppCell | Adult-Epithelial-club_cell-D231|Adult / Lineage, Cell type, age group and donor | 4.18e-07 | 187 | 161 | 8 | ee59d7d3de5879738ff0b9c3ea5e4847fb48cb86 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 4.36e-07 | 188 | 161 | 8 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | facs-Trachea-18m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.53e-07 | 189 | 161 | 8 | ecbe079606406f47d4fc97fe1670790dda8e10de | |
| ToppCell | COVID-19-lung-Secretory|lung / Disease (COVID-19 only), tissue and cell type | 4.53e-07 | 189 | 161 | 8 | 84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25 | |
| ToppCell | facs-Trachea-18m-Endothelial-endothelial_cell_of_trachea|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.53e-07 | 189 | 161 | 8 | e830fa0ddc3dccfaf9e88e8c416ed6aab12e3e3f | |
| ToppCell | facs-Trachea-18m-Endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.53e-07 | 189 | 161 | 8 | f635f3f13bced3bcf796cf55723a2df851f973fe | |
| ToppCell | droplet-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l10|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.53e-07 | 189 | 161 | 8 | 28b9e96a5206b7fdae9b17daf05c8f5d24b6c5ec | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.72e-07 | 190 | 161 | 8 | 38a815abf0ac5cac6071737cadc54a514f62d37d | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.72e-07 | 190 | 161 | 8 | bb1476b44dd49e1dd52a636a91c4600b6d4fbe2e | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.72e-07 | 190 | 161 | 8 | d180205c70b5ca9bc5a01a2e6cb42fcebc7f630d | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 4.91e-07 | 191 | 161 | 8 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | facs-Trachea-24m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.91e-07 | 191 | 161 | 8 | 79b399496bd7322a1d53c43378f48695fd09a5d9 | |
| ToppCell | facs-Trachea-24m-Endothelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.91e-07 | 191 | 161 | 8 | 9c6d5d045781c6506ae80e318427ef1e0d87f45c | |
| ToppCell | facs-Trachea-24m-Endothelial-endothelial_cell_of_trachea|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.91e-07 | 191 | 161 | 8 | 1b1e943709d0c3283a980c7c965ef1f110506a29 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.11e-07 | 192 | 161 | 8 | 5b7093d5af5ae7b0e6d3a464cc56272440ecedad | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 5.11e-07 | 192 | 161 | 8 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | 15|World / Age, Tissue, Lineage and Cell class | 5.31e-07 | 193 | 161 | 8 | a8ad0de955494d6f5929dc44ba46627d06d95453 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.53e-07 | 194 | 161 | 8 | a429d22c8c9d0fd3bfa9f877a6364cecad68db30 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 5.97e-07 | 196 | 161 | 8 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.97e-07 | 196 | 161 | 8 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.97e-07 | 196 | 161 | 8 | 81900dcc9451ff6606ec940c16b559d73247590e | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.45e-07 | 198 | 161 | 8 | af399569c718f5fd971d73a7926768c9311002a3 | |
| ToppCell | metastatic_Brain-Endothelial_cells|metastatic_Brain / Location, Cell class and cell subclass | 6.45e-07 | 198 | 161 | 8 | 97ef7946ef11ac93318c1dd46b548dc01e5a6aba | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.45e-07 | 198 | 161 | 8 | 6ba5e5970109a04ed968bac7ff099ae250c579dc | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.45e-07 | 198 | 161 | 8 | fab3135f03cf23a9f04f0eed543a9dc181f39f5f | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Duct|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.95e-07 | 200 | 161 | 8 | b992eeddee38e6fe3564e9b1850f6b20b89bf47d | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 6.95e-07 | 200 | 161 | 8 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | COVID-19_Mild|World / 5 Neutrophil clusters in COVID-19 patients | 1.38e-06 | 152 | 161 | 7 | 2ff0980dfd8d430cca14649151d856edef115720 | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 1.64e-06 | 156 | 161 | 7 | 10d191e29b16cae8238e8df6c0ff38882253f34e | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.02e-06 | 161 | 161 | 7 | 2d63b279d9a5132e1c09b03930bf9039036d24a2 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte-Chondrocyte_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.48e-06 | 166 | 161 | 7 | 37794a84601a2a949d579663d4a4bb8bc8fb5923 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 2.48e-06 | 166 | 161 | 7 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.48e-06 | 166 | 161 | 7 | 81c546c6d847e49e662b81e71992ca0f7a99e890 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.39e-06 | 174 | 161 | 7 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Proximal_secretory_3|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.39e-06 | 174 | 161 | 7 | 9e5fae9ecc7c0111fc8a252e72b89dc89c0d3a7c | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.65e-06 | 176 | 161 | 7 | 3bbac5c2397535631fce8fa98f6ddb4fe0260351 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.94e-06 | 178 | 161 | 7 | fcbbcc44271515de1969b4732b6441c012693d5f | |
| ToppCell | (3)_Chondrocytes-(32)_Chondro-prehyper-2|(3)_Chondrocytes / Cell class and subclass of bone marrow stroma cells in homeostatis | 4.24e-06 | 180 | 161 | 7 | 708a5c89b9337e281fce4f482892a1c1766c7812 | |
| ToppCell | wk_08-11-Mesenchymal-Chondrocyte-Resting_chondrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.56e-06 | 182 | 161 | 7 | 00a148b1e499bf16325491536d187d4dd6b70c06 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Macroglial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.56e-06 | 182 | 161 | 7 | c00e503f442d44fbae73c5e2dc85be69e294e67a | |
| ToppCell | Epithelial-lung_goblet_cell|World / Lineage, Cell type, age group and donor | 4.72e-06 | 183 | 161 | 7 | 940cbe298e9c53b5622af09264586ed823d3141f | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 4.90e-06 | 184 | 161 | 7 | e6bf826be31e1723e24c366fc5a1cee9b15589bc | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 4.90e-06 | 184 | 161 | 7 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | facs-Trachea-nan-24m-Endothelial|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.07e-06 | 185 | 161 | 7 | dec60254204014083ff3b4aec0cc75410950a486 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 5.07e-06 | 185 | 161 | 7 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | facs-Trachea-nan-24m-Endothelial-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.07e-06 | 185 | 161 | 7 | 201465dc0d7aa0336a36d37805cae1155a5adfe1 | |
| ToppCell | facs-Trachea-nan-24m-Endothelial-endothelial_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.07e-06 | 185 | 161 | 7 | 334f006c3ef33338ff8d649309d3f448733a3a99 | |
| ToppCell | droplet-Heart-nan-18m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.07e-06 | 185 | 161 | 7 | a32d5cb596ebac80eb1ac301055e65d420879ec8 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.26e-06 | 186 | 161 | 7 | bd1185592aedebccd1007dbf2dd2f549fcdf9f42 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.26e-06 | 186 | 161 | 7 | 8eafd4bea692f7ef33de27dd53f9d1fe67deaad8 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.44e-06 | 187 | 161 | 7 | 76bfe8c42430a230a8bdf299575c444fb7780f24 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 5.44e-06 | 187 | 161 | 7 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T2|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 5.44e-06 | 187 | 161 | 7 | f3e37c18ac6471c7992609bbddfa4975571c815c | |
| ToppCell | COVID-19-Epithelial_cells-Airway_basal|COVID-19 / group, cell type (main and fine annotations) | 5.44e-06 | 187 | 161 | 7 | 8407a82e98f56a94ea26562bcb6bbe00a8f41661 | |
| ToppCell | P15-Mesenchymal|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.64e-06 | 188 | 161 | 7 | f1ba0b661621a65c91432e62ba73531bdf18e7c1 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.64e-06 | 188 | 161 | 7 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 6.04e-06 | 190 | 161 | 7 | f1363f7806cfc4f14fbc1b0e8dac2de813a88eee | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 6.04e-06 | 190 | 161 | 7 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.25e-06 | 191 | 161 | 7 | fd01a206763dfb6d52cca67123571936b4a8e1a0 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.25e-06 | 191 | 161 | 7 | 23776c7302cead3881b39127398f3b3e0d27885e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.25e-06 | 191 | 161 | 7 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.69e-06 | 193 | 161 | 7 | ec81c1afdae2e0433a22c8c1fa1c6232526ff7e7 | |
| ToppCell | Epithelial-club_cell|World / Lineage, Cell type, age group and donor | 6.69e-06 | 193 | 161 | 7 | 2bdd09004fa433550958ec42ba4b06271a4aaf7c | |
| ToppCell | human_hepatoblastoma-Tumor_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 6.69e-06 | 193 | 161 | 7 | 503a979328c68b096680b71359a26f02fafdff35 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.69e-06 | 193 | 161 | 7 | 30481fb01c7acf85beae10213f038da86bed6777 | |
| ToppCell | Control-Epithelial_alveolar-Mes-Like-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.92e-06 | 127 | 161 | 6 | 556aaf88719c83f307fa50dfac151136ed05c8ad | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.92e-06 | 194 | 161 | 7 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.92e-06 | 194 | 161 | 7 | e03ba6caed59fa64d4d9b042593469d4a6a3dc10 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 6.92e-06 | 194 | 161 | 7 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_neuro-secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.92e-06 | 194 | 161 | 7 | 2dcc3b99dbedaf8a6916891c85091ddb79d7ee31 | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.16e-06 | 195 | 161 | 7 | bd8e24dd598990204998d1dd853ba7a53dc0107e | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 7.16e-06 | 195 | 161 | 7 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | Epithelial_cells-Club_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 7.16e-06 | 195 | 161 | 7 | b758676abfc4e6930b696d270ecc0ea461b87a54 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.16e-06 | 195 | 161 | 7 | dccc32fcf772e2504de7f663ef0a5bd8e23e92fc | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.16e-06 | 195 | 161 | 7 | 3123e02d2894c83962ba402085b5e6422ebf8c73 | |
| ToppCell | facs-Heart-RA-18m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.16e-06 | 195 | 161 | 7 | 30c75761079fa1e1a3b84d23c88a222f459d5ce5 | |
| ToppCell | facs-GAT-Fat-3m-Endothelial|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.40e-06 | 196 | 161 | 7 | b6cc1f466d45479764080d34b1daeb8243a5a9f3 | |
| ToppCell | facs-GAT-Fat-3m-Endothelial-endothelial_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.40e-06 | 196 | 161 | 7 | ede6104cdfa4ee5287efcca9bbc36677cbf7a8d8 | |
| ToppCell | facs-GAT-Fat-3m-Endothelial-nan|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.40e-06 | 196 | 161 | 7 | 039044ab28c53391c34d8226fb8cf78549e63ef4 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.40e-06 | 196 | 161 | 7 | f40d10ea7714067585493fdc89744714aa427de8 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Degenerative_Distal_Convoluted_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.40e-06 | 196 | 161 | 7 | b8350340d86e4524e9616a427e7f2e116a6fb3be | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.65e-06 | 197 | 161 | 7 | ae0435f4b4a9cdedb1c201fc56921048390097bf | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.65e-06 | 197 | 161 | 7 | 37f6b6f2809b952382eaebb642b0aad6371f4251 | |
| ToppCell | Parenchyma_Control_(B.)-Immune-TX-MoAM-4|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 7.65e-06 | 197 | 161 | 7 | dc1c55e3aacc9d60d0f111c2f20f150ca296f011 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.65e-06 | 197 | 161 | 7 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| Drug | epps | 8.42e-06 | 40 | 159 | 5 | CID000085255 | |
| Drug | Scoulerine [6451-73-6]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 1.10e-05 | 198 | 159 | 9 | 2891_UP | |
| Drug | Hexylcaine hydrochloride [532-76-3]; Up 200; 13.4uM; HL60; HT_HG-U133A | 1.10e-05 | 198 | 159 | 9 | 2708_UP | |
| Drug | Isoniazid [54-85-3]; Up 200; 29.2uM; PC3; HT_HG-U133A | 1.10e-05 | 198 | 159 | 9 | 2083_UP | |
| Disease | kallistatin measurement | 7.66e-06 | 8 | 154 | 3 | EFO_0008196 | |
| Disease | Paroxysmal atrial fibrillation | 1.87e-05 | 156 | 154 | 7 | C0235480 | |
| Disease | familial atrial fibrillation | 1.87e-05 | 156 | 154 | 7 | C3468561 | |
| Disease | Persistent atrial fibrillation | 1.87e-05 | 156 | 154 | 7 | C2585653 | |
| Disease | Atrial Fibrillation | 2.20e-05 | 160 | 154 | 7 | C0004238 | |
| Disease | Zimmerman Laband syndrome | 8.09e-05 | 3 | 154 | 2 | C0796013 | |
| Disease | serpin A9 measurement | 1.61e-04 | 4 | 154 | 2 | EFO_0802062 | |
| Disease | Portal Hypertension | 2.68e-04 | 5 | 154 | 2 | C0020541 | |
| Disease | pseudohypoaldosteronism (implicated_via_orthology) | 4.00e-04 | 6 | 154 | 2 | DOID:4479 (implicated_via_orthology) | |
| Disease | coronary artery disease | COL6A3 NCOA6 APOB RUNX2 TSPAN9 RSBN1 PRDM8 SENP1 LRFN2 CELSR2 DLEC1 BSN SAP130 NOS3 IL6R WNK2 | 5.31e-04 | 1194 | 154 | 16 | EFO_0001645 |
| Disease | LDL cholesterol change measurement | 5.59e-04 | 7 | 154 | 2 | EFO_0007804 | |
| Disease | anxiety, smoking behaviour measurement | 5.59e-04 | 7 | 154 | 2 | EFO_0005230, EFO_0005671 | |
| Disease | psychotic symptoms | 6.18e-04 | 74 | 154 | 4 | EFO_0005940 | |
| Disease | esterified cholesterol measurement, intermediate density lipoprotein measurement | 7.42e-04 | 8 | 154 | 2 | EFO_0008589, EFO_0008595 | |
| Disease | common bile duct neoplasm (is_marker_for) | 7.42e-04 | 8 | 154 | 2 | DOID:4608 (is_marker_for) | |
| Disease | vital capacity | COL6A3 NCOA6 PCLO LGR4 APOB RUNX2 MED1 TENM2 RBM20 TSPAN9 RYR2 SENP1 ATAD2B MYPN AGMO EPHA3 | 7.68e-04 | 1236 | 154 | 16 | EFO_0004312 |
| Disease | ascending aortic diameter | 8.59e-04 | 140 | 154 | 5 | EFO_0021787 | |
| Disease | Bipolar Disorder | 9.39e-04 | 477 | 154 | 9 | C0005586 | |
| Disease | alpha-1-antitrypsin measurement | 9.51e-04 | 9 | 154 | 2 | EFO_0008327 | |
| Disease | pulse pressure measurement | COL6A3 COL27A1 INSR GRM4 DYSF SLC22A17 DENND4C PRDM8 SENP1 PPP3CA ATAD2B MYPN TNRC6A DLEC1 MBD5 ST18 TRAPPC9 | 9.98e-04 | 1392 | 154 | 17 | EFO_0005763 |
| Disease | diabetic nephropathy | 1.17e-03 | 150 | 154 | 5 | EFO_0000401 | |
| Disease | unipolar depression, bipolar disorder | 1.39e-03 | 156 | 154 | 5 | EFO_0003761, MONDO_0004985 | |
| Disease | Tachycardia, Ventricular | 1.44e-03 | 11 | 154 | 2 | C0042514 | |
| Disease | smoking cessation | 1.65e-03 | 325 | 154 | 7 | EFO_0004319 | |
| Disease | lymphangioleiomyomatosis (is_marker_for) | 1.73e-03 | 12 | 154 | 2 | DOID:3319 (is_marker_for) | |
| Disease | low density lipoprotein cholesterol measurement, alcohol consumption measurement | 1.83e-03 | 99 | 154 | 4 | EFO_0004611, EFO_0007878 | |
| Disease | Osteosarcoma | 1.91e-03 | 47 | 154 | 3 | C0029463 | |
| Disease | interleukin 6 receptor subunit alpha measurement | 2.03e-03 | 13 | 154 | 2 | EFO_0008187 | |
| Disease | Fetal Alcohol Spectrum Disorders | 2.03e-03 | 13 | 154 | 2 | C2985290 | |
| Disease | brain cortex volume measurement | 2.03e-03 | 13 | 154 | 2 | EFO_0010287 | |
| Disease | frontotemporal dementia, age at onset | 2.03e-03 | 13 | 154 | 2 | EFO_0004847, MONDO_0017276 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol drinking | 2.04e-03 | 102 | 154 | 4 | EFO_0004329, EFO_0004611 | |
| Disease | creatinine measurement | SIPA1L3 MED1 TSPAN9 PRDM8 PPP3CA CELSR2 SETBP1 MYPN DLEC1 BSN MBD5 UNC80 CCDC158 | 2.22e-03 | 995 | 154 | 13 | EFO_0004518 |
| Disease | Tourette syndrome | 2.28e-03 | 50 | 154 | 3 | EFO_0004895 | |
| Disease | CD209 antigen measurement | 2.36e-03 | 14 | 154 | 2 | EFO_0008077 | |
| Disease | esterified cholesterol measurement, low density lipoprotein cholesterol measurement | 2.36e-03 | 14 | 154 | 2 | EFO_0004611, EFO_0008589 | |
| Disease | diabetic neuropathy (implicated_via_orthology) | 2.36e-03 | 14 | 154 | 2 | DOID:9743 (implicated_via_orthology) | |
| Disease | Schizophrenia | CACNA1B ANK3 SREBF2 GABARAP AMBRA1 GRM4 CFAP65 CBLIF KLF5 KCNN3 MAGEC1 IL6R | 2.38e-03 | 883 | 154 | 12 | C0036341 |
| Disease | myocardial infarction | 2.50e-03 | 350 | 154 | 7 | EFO_0000612 | |
| Disease | anti-neutrophil antibody associated vasculitis | 2.55e-03 | 52 | 154 | 3 | EFO_0004826 | |
| Disease | total phospholipids in lipoprotein particles measurement | 2.70e-03 | 53 | 154 | 3 | EFO_0022315 | |
| Disease | Hypertriglyceridemia | 2.72e-03 | 15 | 154 | 2 | C0020557 | |
| Disease | response to statin, LDL cholesterol change measurement | 2.72e-03 | 15 | 154 | 2 | EFO_0007804, GO_0036273 | |
| Disease | anemia (implicated_via_orthology) | 2.72e-03 | 15 | 154 | 2 | DOID:2355 (implicated_via_orthology) | |
| Disease | coronary artery disease, factor VII measurement | 2.77e-03 | 111 | 154 | 4 | EFO_0001645, EFO_0004619 | |
| Disease | factor VIII measurement, coronary artery disease | 2.96e-03 | 113 | 154 | 4 | EFO_0001645, EFO_0004630 | |
| Disease | phospholipids in medium HDL measurement | 3.00e-03 | 55 | 154 | 3 | EFO_0022295 | |
| Disease | Beta blocking agent use measurement | 3.05e-03 | 114 | 154 | 4 | EFO_0009929 | |
| Disease | diabetic retinopathy (implicated_via_orthology) | 3.10e-03 | 16 | 154 | 2 | DOID:8947 (implicated_via_orthology) | |
| Disease | sickle cell anemia (is_implicated_in) | 3.10e-03 | 16 | 154 | 2 | DOID:10923 (is_implicated_in) | |
| Disease | ovarian cancer (is_implicated_in) | 3.16e-03 | 56 | 154 | 3 | DOID:2394 (is_implicated_in) | |
| Disease | free cholesterol to total lipids in large HDL percentage | 3.16e-03 | 56 | 154 | 3 | EFO_0022279 | |
| Disease | HMG CoA reductase inhibitor use measurement | 3.20e-03 | 189 | 154 | 5 | EFO_0009932 | |
| Disease | triglyceride measurement, high density lipoprotein cholesterol measurement | 3.25e-03 | 274 | 154 | 6 | EFO_0004530, EFO_0004612 | |
| Disease | atrial fibrillation | 3.44e-03 | 371 | 154 | 7 | EFO_0000275 | |
| Disease | von Willebrand factor measurement, coronary artery disease | 3.45e-03 | 118 | 154 | 4 | EFO_0001645, EFO_0004629 | |
| Disease | cholesterol in IDL measurement | 3.49e-03 | 58 | 154 | 3 | EFO_0021899 | |
| Disease | total lipids in medium HDL measurement | 3.49e-03 | 58 | 154 | 3 | EFO_0022310 | |
| Disease | response to radiation, Urinary retention | 3.50e-03 | 17 | 154 | 2 | GO_0009314, HP_0000016 | |
| Disease | muscular dystrophy (is_implicated_in) | 3.50e-03 | 17 | 154 | 2 | DOID:9884 (is_implicated_in) | |
| Disease | Uremia | 3.50e-03 | 17 | 154 | 2 | C0041948 | |
| Disease | Lipidemias | 3.50e-03 | 17 | 154 | 2 | C1706412 | |
| Disease | cholesterol to total lipids in chylomicrons and extremely large VLDL percentage | 3.50e-03 | 17 | 154 | 2 | EFO_0022232 | |
| Disease | Familial Progressive Myoclonic Epilepsy | 3.50e-03 | 17 | 154 | 2 | C0751777 | |
| Disease | Atypical Inclusion-Body Disease | 3.50e-03 | 17 | 154 | 2 | C0751776 | |
| Disease | Myoclonic Epilepsies, Progressive | 3.50e-03 | 17 | 154 | 2 | C0751778 | |
| Disease | Biotin-Responsive Encephalopathy | 3.50e-03 | 17 | 154 | 2 | C0751780 | |
| Disease | May-White Syndrome | 3.50e-03 | 17 | 154 | 2 | C0751782 | |
| Disease | Dentatorubral-Pallidoluysian Atrophy | 3.50e-03 | 17 | 154 | 2 | C0751781 | |
| Disease | Fetal Alcohol Syndrome | 3.50e-03 | 17 | 154 | 2 | C0015923 | |
| Disease | Hyperlipidemia | 3.50e-03 | 17 | 154 | 2 | C0020473 | |
| Disease | ferritin measurement | 3.56e-03 | 119 | 154 | 4 | EFO_0004459 | |
| Disease | cholesterol in medium HDL measurement | 3.66e-03 | 59 | 154 | 3 | EFO_0021903 | |
| Disease | total lipids in IDL | 3.84e-03 | 60 | 154 | 3 | EFO_0022161 | |
| Disease | Insulin Resistance | 3.84e-03 | 60 | 154 | 3 | C0021655 | |
| Disease | Insulin Sensitivity | 3.84e-03 | 60 | 154 | 3 | C0920563 | |
| Disease | free cholesterol to total lipids in medium HDL percentage | 3.84e-03 | 60 | 154 | 3 | EFO_0022282 | |
| Disease | very low density lipoprotein cholesterol measurement, esterified cholesterol measurement | 3.92e-03 | 18 | 154 | 2 | EFO_0008317, EFO_0008589 | |
| Disease | Action Myoclonus-Renal Failure Syndrome | 3.92e-03 | 18 | 154 | 2 | C0751779 | |
| Disease | Hypercholesterolemia, Familial | 3.92e-03 | 18 | 154 | 2 | C0020445 | |
| Disease | free cholesterol in IDL measurement | 4.02e-03 | 61 | 154 | 3 | EFO_0022181 | |
| Disease | response to opioid | 4.02e-03 | 61 | 154 | 3 | EFO_0008541 | |
| Disease | phospholipids in HDL measurement | 4.02e-03 | 61 | 154 | 3 | EFO_0022293 | |
| Disease | systemic lupus erythematosus (is_implicated_in) | 4.21e-03 | 62 | 154 | 3 | DOID:9074 (is_implicated_in) | |
| Disease | free cholesterol in very large HDL measurement | 4.21e-03 | 62 | 154 | 3 | EFO_0022273 | |
| Disease | angina pectoris | 4.24e-03 | 125 | 154 | 4 | EFO_0003913 | |
| Disease | cardiomyopathy (is_implicated_in) | 4.37e-03 | 19 | 154 | 2 | DOID:0050700 (is_implicated_in) | |
| Disease | sodium-coupled monocarboxylate transporter 1 measurement | 4.37e-03 | 19 | 154 | 2 | EFO_0802076 | |
| Disease | triglycerides to total lipids in IDL percentage | 4.40e-03 | 63 | 154 | 3 | EFO_0022329 | |
| Disease | cholangiocarcinoma (is_marker_for) | 4.60e-03 | 64 | 154 | 3 | DOID:4947 (is_marker_for) | |
| Disease | prostate adenocarcinoma (is_implicated_in) | 4.83e-03 | 20 | 154 | 2 | DOID:2526 (is_implicated_in) | |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Positive | 5.01e-03 | 131 | 154 | 4 | C4704862 | |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Negative | 5.01e-03 | 131 | 154 | 4 | C4552091 | |
| Disease | Juvenile arthritis | 5.01e-03 | 131 | 154 | 4 | C3495559 | |
| Disease | Juvenile psoriatic arthritis | 5.01e-03 | 131 | 154 | 4 | C3714758 | |
| Disease | total lipids in very large HDL measurement | 5.02e-03 | 66 | 154 | 3 | EFO_0022312 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NFTLTASSLEPAPSS | 316 | Q14264 | |
| VLSFFPTAPASRASA | 251 | B3EWF7 | |
| SPISSLPALFDQTAS | 671 | P55198 | |
| VAAVSSVSPATPFQS | 171 | Q15059 | |
| FFLPASLSANNTPTR | 571 | Q9UJX2 | |
| PTTVQFTIEALPSSA | 31 | O75871 | |
| DNFETSLLPFTIPTS | 76 | Q86XM0 | |
| PVAFSVVPTAATAVS | 896 | P0C0L5 | |
| PLVPSLSSAFEIVFS | 411 | Q6ZNB7 | |
| ASFCQPETVPTSFVS | 631 | Q4VNC1 | |
| FSVVSPASSAVLPAV | 466 | Q9UIF9 | |
| PRFISPASQLAITFS | 691 | Q14833 | |
| ATLVTQEFFNPSTPV | 141 | Q8N6F1 | |
| SSAPFLSSTTVLFRP | 1326 | Q9NYQ6 | |
| SSAPFIASSSVLFRP | 1251 | Q9HCU4 | |
| PASARATTPSFSFVQ | 331 | Q9C0C7 | |
| IVSSIAAFSPSPGFS | 166 | Q9BTZ2 | |
| TPTTNFDTFPAAILT | 641 | Q00975 | |
| TFLSPAQSEASPVAS | 1111 | Q8NB25 | |
| ATSLESFTNAPPTTI | 436 | Q76M96 | |
| PLPVFSTFVLTGASA | 251 | Q7Z401 | |
| AAAIPSTRFPSNAIA | 156 | Q5T481 | |
| QSSPTFPLASVGTTF | 496 | Q5T481 | |
| QPPLSATFTVTVAVA | 651 | Q9Y5G8 | |
| PTPVLISSAAAQAAA | 466 | Q8TB72 | |
| AVFPRAPTANTASTE | 856 | Q6DT37 | |
| LFTLVPTAFSSSVPA | 506 | Q9H4D5 | |
| SAAPTTSPIVLTASF | 2321 | Q8WXI7 | |
| PQSTLTFEFSEVPSL | 2886 | Q8WXI7 | |
| PNTPLSTFLFDSLST | 3721 | Q8WXI7 | |
| FPASTVFPQVSETTA | 11786 | Q8WXI7 | |
| ISNATPLPVTYASSA | 971 | Q99102 | |
| FSTPVPADSTSLLVS | 331 | O60320 | |
| IVSSIAAFSPSPGFS | 166 | Q6PKH6 | |
| LSIFQSSPESTQSPF | 141 | O60732 | |
| PVSPSFSSTLVSLFQ | 271 | O60732 | |
| ASTNATIPITTTPFA | 1971 | Q2M2H8 | |
| SPSLVQVYTSPAAVA | 6 | Q86UW9 | |
| ITFSTDSLSAPAPQV | 176 | Q5T848 | |
| QDIPSFSPIFLLSTS | 856 | Q9ULI0 | |
| VENPSVSFASSFPLI | 16 | Q6ZU64 | |
| VVSASRSPASVFPAF | 2076 | Q5HYC2 | |
| LPTIPSASDFNTVLS | 2386 | Q2LD37 | |
| TTQSTLFPVPADSRA | 3126 | Q9UPA5 | |
| VSPSRSFPIFQILTS | 161 | Q5VYM1 | |
| FPAQVSSFPSSAVTN | 506 | P18146 | |
| SVFNFLTLPETASLP | 646 | Q9BRR8 | |
| ASPVTTATPLFDAVT | 2446 | Q9Y6V0 | |
| PSSFQAAPTSVTQFL | 2656 | Q9Y6V0 | |
| EVLFAAFSSAAPPTV | 291 | O43157 | |
| TAFRAPPSSNSTAIL | 106 | Q9UGI6 | |
| LLASPTSPVTAEFSS | 676 | Q9H706 | |
| RESPATPVSFQAAST | 791 | O95259 | |
| SSEAPFPNVSTSLLT | 526 | Q86TH1 | |
| FSFAPLITAISISPE | 766 | Q9BXB1 | |
| LFFFVNNVIPPTSAT | 76 | O95166 | |
| TVAVPTVAAFPNTSS | 771 | P06213 | |
| AISVPISSDASPFIL | 1306 | Q7Z3U7 | |
| PTVLSIFLFNAPETS | 81 | Q8NGJ7 | |
| STSSFFPILAPAVGS | 1311 | Q9UKK3 | |
| TLFPPDVIASIFSSA | 56 | Q9Y5U4 | |
| IPTPDSDVFTFSVSL | 266 | Q5R372 | |
| RQALTFFLDITSPPS | 856 | P29474 | |
| SEAISSSSIPQFPIT | 661 | Q8IV76 | |
| TQPSFTFTLPAAATA | 546 | A8CG34 | |
| APVFTALPSFTSLTN | 691 | Q86XN7 | |
| ALPSFTSLTNNFPLT | 696 | Q86XN7 | |
| PFTALPTDTAISVTF | 261 | Q8NGE8 | |
| ARPQFITPVFINSSS | 1651 | Q14686 | |
| VATTQIPSVTFPSAS | 106 | Q8TAX7 | |
| SLVFSVSFPPQLSVR | 141 | Q3MIT2 | |
| IPSRFSTPEFTILNT | 2641 | P04114 | |
| SVTSSAYPNPSILIA | 46 | P27352 | |
| VQDSSSVPLPTFLVA | 356 | P08887 | |
| LQFSSSVQIDPPFSS | 96 | Q2UY09 | |
| LFFFVNNTIPPTSAT | 76 | Q9H0R8 | |
| ASLTPAFFSQTPIIL | 351 | P28324 | |
| AAAPTTSVFSFSPVN | 531 | Q9BQW3 | |
| RFSADSSNVVPSPLA | 341 | Q9NQL9 | |
| FPSNSTSVFRSSPVL | 411 | Q9NQL9 | |
| AQPLVSPISAFLTAT | 951 | Q7Z3S7 | |
| LFSVPSQLRAFTVPS | 251 | Q9H6X5 | |
| TSAFIETPIPLFTQS | 321 | Q12934 | |
| LASAAPSQSIFFSPV | 56 | P05154 | |
| VAVFFSNTPTRASPQ | 2511 | P12111 | |
| LPSPTSETVLTVAAF | 111 | Q19T08 | |
| LFFFVNNTIPPTSAT | 76 | Q9BY60 | |
| PLPVFSTFVLTGSSA | 251 | Q5VZ89 | |
| PQNISLPSAASFTFS | 146 | Q9Y653 | |
| PSAFQSLRTPSASAL | 1786 | Q12955 | |
| TTPALVLAPAQFLSS | 586 | Q8IZC6 | |
| SELSSPPRQFAAVSI | 416 | P29320 | |
| LPSGSLTPAFFTAQT | 321 | P41970 | |
| IPTVFSFNPANTTTS | 291 | Q3C1V0 | |
| NVLNTPSSAAFPTAS | 531 | Q9P267 | |
| QPAFATVTPSSSSVL | 931 | Q53TQ3 | |
| SPSFIVSPLNSSSAL | 306 | Q9BVP2 | |
| NTSSAGTLTQVPFFP | 41 | Q5M9N0 | |
| QETSVAPFALPTVSL | 236 | Q8WUI4 | |
| ASVNLFPTISVAPSA | 416 | Q9Y613 | |
| TQGLAVSTISSFFPP | 191 | P08637 | |
| ASSSLPAVVVETFPA | 486 | O00499 | |
| NSSATCPFLSETIIP | 76 | Q96MH7 | |
| APPTSIALQVFFTAR | 1701 | Q9Y238 | |
| SLTQAAFTPIPVDTS | 856 | Q92736 | |
| VLATPSLSASFNAPL | 91 | O75923 | |
| TTGFPSLITIFSAPN | 296 | Q08209 | |
| PVAFSVVPTAAAAVS | 896 | P0C0L4 | |
| PSFSSITSANSVDLP | 286 | Q15648 | |
| ASPSNSSTVPVSEFL | 6 | Q8NGH5 | |
| AASATPFALPITSTS | 116 | Q9BVL2 | |
| LASVTFFATSDSQPP | 401 | Q6J4K2 | |
| FPSISSLTESRFSNP | 376 | Q13950 | |
| QLLTTASSSFPPASE | 751 | Q5VWQ0 | |
| LNASFLASPTELPSA | 536 | Q8NBS3 | |
| LASVESVPFSFDPNT | 296 | Q9UPQ4 | |
| DLVPSESNAFLPSSV | 231 | Q96R06 | |
| TFSSPNFATIPQDTV | 196 | Q9BUD6 | |
| PLPATSSFSFASLLN | 286 | Q8WUG5 | |
| AANVLFPSAASFPLT | 271 | Q9UD57 | |
| STSAPSLIFILPSIF | 406 | Q8WUX1 | |
| TFIPLNSDASATLPL | 11 | P28069 | |
| FSQPARSFSQLSPLV | 501 | Q9NQV8 | |
| FITPSTTVPSVFELN | 556 | Q9HCL2 | |
| SQTPTPSSTFFQAEL | 326 | Q9P0U3 | |
| VLFTSTCAFPSSTLP | 1571 | O60292 | |
| IISSPLSTFFSAAPG | 1031 | Q9NT68 | |
| PPSSFSRFSQAVILS | 71 | Q99935 | |
| TAVAQAPPAVASSSL | 31 | Q9UHV2 | |
| APPAVASSSLFDLSV | 36 | Q9UHV2 | |
| LLALSTFSTSPQDFP | 391 | Q92935 | |
| LETPSQNIFFSPVSV | 61 | Q86WD7 | |
| NYLAPVSASVSPSAV | 301 | P11831 | |
| FNFPSQAITSPRATV | 476 | O60284 | |
| AAATIPANSSDAPFI | 121 | Q9H2A9 | |
| PFQISLPSSELASSS | 836 | Q15735 | |
| VTTASSAQTFPISAP | 131 | Q8TF68 | |
| DPFSSPLLSIIQTFS | 896 | O75762 | |
| ENPLLSSQFTFTPTE | 3231 | Q8N2C7 | |
| SAPFTQPLSSNEIFR | 281 | Q9BUI4 | |
| QSEAPPSLVSFAVSS | 316 | Q9UMS6 | |
| VTSSLAPPVTAVFVL | 446 | A0PJK1 | |
| PPFSVTTANGTISFT | 286 | Q86WA9 | |
| GNIFFSPVSISTTLA | 71 | Q86U17 | |
| ASAPALAPQVATSYT | 336 | Q76KD6 | |
| PFASLTATSQPIAAA | 221 | O95155 | |
| SFTQVTLPSFSPSAA | 91 | Q12772 | |
| NPFSAAPAATTVVQT | 636 | Q9H0E3 | |
| PGAASQFIAATPTSL | 641 | Q6IQ55 | |
| VPLQTSDSFLRFPSS | 211 | Q2MV58 | |
| PVFTISTNFPIIAVT | 361 | Q8NE00 | |
| NVASLAFPFTTPVLV | 46 | Q6ZNG0 | |
| TVNTTVFNASAPLAP | 686 | Q9BY07 | |
| PFTVLVPSVSSFSSR | 396 | Q9NY15 | |
| IVSSPLSTFFRSSPE | 966 | Q9P273 | |
| LESFPAVLPSVSVSQ | 841 | Q68DE3 | |
| PLVPLRTFQSSLFSS | 31 | A1L4Q6 | |
| AAPSFQFINPTTITS | 441 | Q6PJI9 | |
| VNLPPSSTSTIADTF | 486 | Q9UJ78 | |
| SSFNPATFQSLLIPR | 551 | Q8N5H7 | |
| PSVFFTRVSTLPATS | 886 | Q96Q05 | |
| LPQFPSSLATVSASV | 1066 | Q9Y3S1 | |
| DSFTVLSENPPSFTI | 21 | Q9H446 | |
| VPSNFQSLVASSPAA | 761 | Q9Y6X0 | |
| ILTTATPAFSPFTLV | 846 | Q9Y334 | |
| DDFPLTLASAVPSQT | 91 | A0A1B0GX49 | |
| FIPRSAQPITFTTAS | 166 | Q14106 | |
| PSTTAAPLLSLASAF | 916 | Q96J92 | |
| ILDSFAAAPVPTTTL | 241 | P18583 | |
| ISRFFAQSQSLTPSP | 1856 | Q8NDV7 | |
| PSFPSLSAANLVIAI | 46 | O75954 | |
| SLNPAAFVPITSSTD | 1261 | Q6EMB2 | |
| VAIASIQSAATFPDP | 31 | P22415 | |
| APTQALPEFTSIFSS | 181 | Q13887 | |
| PIFARSQASALTATP | 216 | Q9ULH4 | |
| FFPSTNTTAATVAPS | 726 | Q86TC9 |